scholarly article | Q13442814 |
P2093 | author name string | Yoshimura I | |
Suzuki S | |||
Tadakuma T | |||
Hayakawa M | |||
P2860 | cites work | Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization | Q40780995 |
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes | Q40988230 | ||
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors | Q41019039 | ||
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies | Q45885920 | ||
Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells | Q45886533 | ||
P433 | issue | 7 | |
P921 | main subject | gene therapy | Q213901 |
P304 | page(s) | S5-8 | |
P577 | publication date | 2001-07-01 | |
P1433 | published in | International Journal of Urology | Q15767019 |
P1476 | title | Suicide gene therapy on LNCaP human prostate cancer cells | |
P478 | volume | 8 |
Q39998447 | ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer |
Q40416863 | Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells |
Q45870274 | Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells |
Q40608060 | Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy |
Q40036198 | Development of an adenoviral vector with robust expression driven by p53. |
Q34557622 | Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. |
Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
Q45858785 | Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo |
Q38295983 | Targeted prodrug approaches for hormone refractory prostate cancer. |
Q36519354 | The kallikrein world: an update on the human tissue kallikreins |
Q24791038 | Transcriptional Targeting in Cancer Gene Therapy |
Q40262672 | Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer |
Search more.